Claire Gregg
explored the novel question of cross-border infringement in the Federal Court of Australia's
Scidera decision. She discussed whether a diagnostic method claim is infringed when part of the process occurs offshore, noting that the court seems open to an "in substance" approach similar to that seen in UK authorities.
Rose Hughes
provided a detailed review of 2025 EPO case law trends regarding antibodies and biologics. Her analysis highlighted the Boards of Appeal's strict approach to added matter and the complex role of post-published data, which can sometimes undermine a patentee's claim to sufficiency or inventive step.
Rose Hughes also
examined the first EPO Board of Appeal decision to apply the
G 1/23 ruling on "black-box" prior art. She explained that while a non-reproducible commercial product can destroy novelty, the decision confirms that trade secrets may still protect against an inventive step attack if the skilled person cannot deduce how to modify the product.
Katfriend
Aislinn Fanning reviewed the book
Bioinked Boundaries by Pratap Devarapalli. The post offers a comparative analysis of patentability for 3D bioprinted tissues and bioinks across the US, Europe, and Australia, discussing how patent systems must balance innovation incentives with the ethical implications of patenting life-mimicking technologies.